Desh Rakshak Aushdhalaya Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 531521
₹26.90
▲ 0.00 (0.00%)
Sept. 1, 2026 · BSE · bse_bhavcopy
Quality
53/100
Moderate
Valuation
63/100
Fairly Valued
Momentum
97/100
Bullish

QVM read Momentum-led Quality Moderate, Valuation Fairly Valued, Momentum Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹15 Cr
PE (TTM)
27.7
Industry median 36.1 (152 companies)
Price to Book
1.2
PEG (TTM)
-0.7
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
190.5
Free Cash Flow
₹-2 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
-36.36%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-23.37%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
-24.29%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
-16.67%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
-36.31%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
2.49
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.21
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
3.34
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
9.66%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
16.18%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
14.29%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
2.71%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
5.83%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
4.27%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 7 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.21)
  • No Return on equity is 15% or more (4.3%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 5 met
  • No Price sits in the Buy zone of its own historical PE range (Overvalued (above its own historical PE range))
  • No Valuation score is Undervalued (70 or more)
  • Yes Momentum score is Bullish (70 or more)
  • Yes Price is above the 5, 10 and 20 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.0%
Low 26.9000 · High 26.9000
1W return
0.0%
Low 26.9000 · High 26.9000
1M return
190.5%
Low 25.7500 · High 27.0000
52W return
190.5%
Low 25.7500 · High 27.0000
Lifetime High ₹26.9000 (Aug. 13, 2026)
Lifetime Low ₹3.9000 (March 19, 2021)

Full price history and technicals →

EMA & SMA

Bullish5
Bearish0
5D
24.3
10D
19.7
20D
14.5
50D
9.8
100D
8.3

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
100.0%
Month avg. delivery
100.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

26.90
Pivot
First resistance26.90
Second resistance26.90
Third resistance26.90
First support26.90
Second support26.90
Third support26.90
Day RSI93.5
Day MFI97.2
Day MACD5.46
Day MACD signal3.19

Beta

1M—
3M—
1Y—
3Y—

Price change analysis

↑ 190.5%
Over 1 Month
LowHigh
25.7527.00
↑ 190.5%
Over 3 Months
LowHigh
25.7527.00
↑ 190.5%
Over 6 Months
LowHigh
25.7527.00
↑ 190.5%
Over 1 Year
LowHigh
25.7527.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 27.7 (own history: 5.7–9.5)
Overvalued (above its own historical PE range)
Revenue (June 30, 2026)
₹1 Cr
Net profit (June 30, 2026)
₹0 Cr
Basic EPS (June 30, 2026)
₹0.1400

Ranks #170 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter50.03%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 50.03% in Jun 2026 qtr

All shareholding details →

Corporate Announcements

All 4 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
27 Sep 2026 Insider Trading / SAST Desh Rakshak Aushdhalaya Ltd - 531521 - Closure of Trading Window
25 Sep 2026 AGM/EGM Desh Rakshak Aushdhalaya Ltd - 531521 - Shareholder Meeting / Postal Ballot-Outcome of AGM
25 Sep 2026 Company Update Desh Rakshak Aushdhalaya Ltd - 531521 - Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
25 Sep 2026 Company Update Desh Rakshak Aushdhalaya Ltd - 531521 - Announcement under Regulation 30 (LODR)-Change in Directorate

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.21)
  • Healthy liquidity (Current Ratio 2.49)

Weaknesses

  • Low Return on Equity (4.3%)
  • Declining revenue YoY (-36.3%)
  • Declining profit YoY (-16.7%)

Opportunities

Data unavailable.

Threats

  • RSI in overbought territory (93.5)

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Desh Rakshak Aushdhalaya Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.